Cytosolic sequestration of spatacsin by Protein Kinase A and 14-3-3 proteins.
14-3-3s
Hereditary spastic paraplegia (HSP)
Intracellular trafficking
Protein Kinase A (PKA)
Protein-protein interactions (PPI)
SPG11/Spatacsin
Journal
Neurobiology of disease
ISSN: 1095-953X
Titre abrégé: Neurobiol Dis
Pays: United States
ID NLM: 9500169
Informations de publication
Date de publication:
Nov 2022
Nov 2022
Historique:
received:
23
05
2022
revised:
06
09
2022
accepted:
08
09
2022
pubmed:
13
9
2022
medline:
2
11
2022
entrez:
12
9
2022
Statut:
ppublish
Résumé
Mutations in SPG11, encoding spatacsin, constitute the major cause of autosomal recessive Hereditary Spastic Paraplegia (HSP) with thinning of the corpus callosum. Previous studies showed that spatacsin orchestrates cellular traffic events through the formation of a coat-like complex and its loss of function results in lysosomal and axonal transport impairments. However, the upstream mechanisms that regulate spatacsin trafficking are unknown. Here, using proteomics and CRISPR/Cas9-mediated tagging of endogenous spatacsin, we identified a subset of 14-3-3 proteins as physiological interactors of spatacsin. The interaction is modulated by Protein Kinase A (PKA)-dependent phosphorylation of spatacsin at Ser1955, which initiates spatacsin trafficking from the plasma membrane to the intracellular space. Our study provides novel insight in understanding spatacsin physio-pathological roles with mechanistic dissection of its associated pathways.
Identifiants
pubmed: 36096339
pii: S0969-9961(22)00250-9
doi: 10.1016/j.nbd.2022.105858
pii:
doi:
Substances chimiques
14-3-3 Proteins
0
Cyclic AMP-Dependent Protein Kinases
EC 2.7.11.11
SPG11 protein, human
0
Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
105858Subventions
Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/M017222/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N026004/1
Pays : United Kingdom
Informations de copyright
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no conflict of interest.